1. Home
  2. NPKI vs LXRX Comparison

NPKI vs LXRX Comparison

Compare NPKI & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NPK International Inc.

NPKI

NPK International Inc.

N/A

Current Price

$11.36

Market Cap

1.1B

Sector

Industrials

ML Signal

N/A

LXRX

Lexicon Pharmaceuticals Inc.

N/A

Current Price

$1.69

Market Cap

996.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NPKI
LXRX
Founded
1932
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
996.7M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
NPKI
LXRX
Price
$11.36
$1.69
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
★ $20.33
$4.55
AVG Volume (30 Days)
720.5K
★ 2.9M
Earning Date
10-29-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 126.16
77.78
EPS
★ 0.26
N/A
Revenue
★ $747,763,000.00
$49,803,000.00
Revenue This Year
$15.38
N/A
Revenue Next Year
$10.54
N/A
P/E Ratio
$44.15
★ N/A
Revenue Growth
58.59
★ 60.24
52 Week Low
$10.73
$1.10
52 Week High
$16.50
$2.68

Technical Indicators

Market Signals
Indicator
NPKI
LXRX
Relative Strength Index (RSI) 31.97 30.34
Support Level $11.20 $1.50
Resistance Level $14.86 $1.81
Average True Range (ATR) 0.38 0.12
MACD 0.01 -0.01
Stochastic Oscillator 12.45 0.00

Price Performance

Historical Comparison
NPKI
LXRX

About NPKI NPK International Inc.

NPK International Inc is a temporary worksite access solutions company that manufactures, sells, and rents recyclable composite matting products, along with a full suite of services, including planning, logistics, and site restoration. The company generates majority of revenue from the rental of recyclable composite matting systems, along with related site construction and services to customers in various markets including power transmission, oil and natural gas exploration and production, pipeline, renewable energy, petrochemical, construction and other industries within the United States and United Kingdom. It generates maximum revenue from United States.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: